The DOI matches its Crossref record; 135 of the 137 references it cites were found in a registry or an index.
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Open accessAbstract
Hepatic cirrhosis and hepatocellular carcinoma (HCC) are the most common causes of death in patients with chronic liver disease. Chronic liver injury of virtually any etiology triggers inflammatory and wound-healing responses that in the long run promote the development of hepatic fibrosis and HCC. Here, we review the role of the transcription factor nuclear factor-κB (NF-κB), a master regulator of inflammation and cell death, in the development of hepatocellular injury, liver fibrosis and HCC, with a particular focus on the role of NF-κB in different cellular compartments of the liver. We propose that NF-κB acts as a central link between hepatic injury, fibrosis and HCC, and that it may represent a target for the prevention or treatment of liver fibrosis and HCC. However, NF-κB acts as a two-edged sword and inhibition of NF-κB may not only exert beneficial effects but also negatively impact hepatocyte viability, especially when NF-κB inhibition is pronounced. Finding appropriate targets or identifying drugs that either exert only a moderate effect on NF-κB activity or that can be specifically delivered to nonparenchymal cells will be essential to avoid the increase in liver injury associated with complete NF-κB blockade in hepatocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the decisive factor is that NF-κB-activation additionally causes a significantly increased resistance against apoptosis in aHSCs.[21]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Cited by
Sorted by citations
Items 701–800 of 999
Polyphenols from Tamarix nilotica: LC–ESI-MSn Profiling and In Vivo Antifibrotic Activity
Sekkien, A., Swilam, N., Ebada, S. S., Esmat, A., El‐Khatib, A. H., Linscheid, M. W., & Singab, A. N. B. (2018) · Molecules · doi:10.3390/molecules23061411 · Cited by 17
Hu, S., Bae, M., Park, Y., & Lee, J. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108452 · Cited by 17
Mechanisms of Metal-Induced Hepatic Inflammation
Subramaniam, N., & Mann, K. K. (2024) · Current Environmental Health Reports · doi:10.1007/s40572-024-00463-6 · Cited by 18
Lin, A., Xiong, M., Tang, B., Jiang, A., Shen, J., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2025) · Hepatology International · doi:10.1007/s12072-025-10838-y · Cited by 17
MiR-1188 at the imprintedDlk1-Dio3domain acts as a tumor suppressor in hepatoma cells
Cui, W., Huang, Z., He, H., Gu, N., Qin, G., Lv, J., Zheng, T., Sugimoto, K., & Wu, Q. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-11-1576 · Cited by 16
Saberi, S. E. M., & Chua, L. S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122170 · Cited by 18
Abhilash, P. A., Harikrishnan, R., & Indira, M. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0255-6 · Cited by 16
Siling, B., Chu, F., Wang, M., Bi, L., Mao, P., Zhang, H., Wang, P., Guo, W., Xu, L., Ren, L., et al. (2016) · Molecules · doi:10.3390/molecules21111599 · Cited by 16
Hsia, C., Velusamy, M., Jayakumar, T., Chen, Y.-J., Hsia, C., Tsai, J., Teng, R.-D., & Sheu, J. (2018) · Cells · doi:10.3390/cells7110217 · Cited by 16
Choi, J., Moon, S.-H., Bae, H., Kim, Y.-W., Lee, D., Kim, S., Seo, Y., Wang, H. S., Choi, Y. W., Lee, M. W., et al. (2019) · Molecules · doi:10.3390/molecules24162883 · Cited by 16
Jin, G., Su, Y., Dong, Q., Zhao, X., Zhang, L., & Yan, X. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.130 · Cited by 16
Cong, W., Sun, Y. M., Sun, Y., Yan, W.-B., Zhang, Y.-L., Gao, Z., Wang, C., Hou, G., & Zhang, J. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1953996 · Cited by 16
Gong, L., Liao, L., Dai, X., Xue, X., Peng, C. Y., & Li, Y. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.08.009 · Cited by 17
Plant-based foods and hepatocellular carcinoma: A review on mechanistic understanding
Saeed, R. A., Maqsood, M., Saeed, R. A., Muzammil, H. S., Khan, M. I., Asghar, L., Nisa, S. U., Rabail, R., & Aadil, R. M. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2095974 · Cited by 17
Depletion of hepatic stellate cells inhibits hepatic steatosis in mice
Kawahara, A., Kanno, K., Yonezawa, S., Otani, Y., Kobayashi, T., Tazuma, S., & Ito, M. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15974 · Cited by 16
Ko, J., Yeh, W., Huang, W., & Yang, H. (2019) · Journal of Food Science · doi:10.1111/1750-3841.14645 · Cited by 16
Xun, Y., Chen, G., Tang, G., Zhang, C., Zhou, S., Fong, T.-L., Chen, Y., Xiong, R.-G., Wang, N., & Feng, Y. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107733 · Cited by 16
Niu, X.-N., Zhang, Y., Cheng, M., Yin, N., Wu, Y., Shi, W., Yang, Y.-L., Zhu, L., Huang, C., & Li, J. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109006 · Cited by 15
Li, X., Xie, W., Pan, Q., Zhang, X., Zhang, L., Zhao, N., Xie, Q., Ding, J., & Chai, J. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-022-01024-w · Cited by 16
Majhi, S. S., Singh, S. K., Biswas, P., Debbarma, R., Parhi, J., Khatei, A., Mangang, Y. A., Waikhom, G., & Patel, A. B. (2023) · Fish and Shellfish Immunology Reports · doi:10.1016/j.fsirep.2023.100112 · Cited by 15
Shi, H., Duan, X., Dong, J., Tao, Y., & Yang, L. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117963 · Cited by 15
Candia, A. A., Lean, S. C., Zhang, C. X. W., McKeating, D. R., Cochrane, A. L. K., Gulacsi, E., Herrera, E. A., Krause, B. J., & Sferruzzi-Perri, A. N. (2024) · Antioxidants · doi:10.3390/antiox13040411 · Cited by 17
Kumar, V., Kumar, R. K., Gurusubramanian, G., Rathore, S. S., & Roy, V. K. (2024) · 3 Biotech · doi:10.1007/s13205-024-04012-8 · Cited by 15
Cheng, Z., Li, F., Qie, Y., Sun, J., Wang, Y., Zhao, Y., & Nie, G. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c04820 · Cited by 19
Romualdo, G. R., Goto, R. L., Fernandes, A. A. H., Cogliati, B., & Barbisan, L. F. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.08.020 · Cited by 15
Cell Therapy in Chronic Liver Disease
Alhomrani, M., Lim, R., & Sievert, W. (2016) · Stem cells in clinical applications · doi:10.1007/978-3-319-46693-4_2 · Cited by 15
Wu, T., Zhang, Q., & Song, H. (2018) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902018000417449 · Cited by 15
Vallée, D., Blanc, M., Lebeaupin, C., & Bailly‐Maitre, B. (2020) · médecine/sciences · doi:10.1051/medsci/2020008 · Cited by 16
Ren, C., Ren, X., Cao, D., Zhao, H., Zhai, Z., Li, H., Li, Y., Fu, X., He, J., & Zhao, H. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12836 · Cited by 15
Plant Compounds for the Treatment of Diabetes, a Metabolic Disorder: NF-κB as a Therapeutic Target
Ravi, S., Punabaka, J., Shanmugam, B., Ganjikunta, V. S., Shanmugam, K. R., & Kesireddy, S. R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200730221035 · Cited by 15
Bai, X., Li, M., Wang, X., Chang, H., Ni, Y., Li, C., He, K., Wang, H., Yang, Y., Tian, T., et al. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04332-7 · Cited by 15
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation
Pierantonelli, I., Lioci, G., Gurrado, F., Giordano, D. M., Rychlicki, C., Bocca, C., Trozzi, L., Novo, E., Panera, N., Stefanis, C. D., et al. (2020) · Liver International · doi:10.1111/liv.14712 · Cited by 14
Adeyanju, A. A., Asejeje, F. O., Molehin, O. R., Owoeye, O., Olatoye, E. O., & Ekpo, E. N. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2020-0202 · Cited by 15
Sanhueza, S., Tobar, N., Cifuentes, M., Quenti, D., Varı́, R., Scazzocchio, B., Masella, R., Herrera, K., Paredes, A., Morales, G., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00811-8 · Cited by 15
Cierpka, R., Weiskirchen, R., & Asimakopoulos, A. (2021) · Cells · doi:10.3390/cells10092184 · Cited by 15
Zárate, M. A., Dios, R. K. D., Balasubramaniyan, D., Zheng, L., Sherlock, L. G., Rozance, P. J., & Wright, C. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.706774 · Cited by 17
The Roles and Mechanisms of lncRNAs in Liver Fibrosis
Wang, Z., Yang, X., Gui, S., Yang, F., Cao, Z., Cheng, R., Xia, X., & Li, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.779606 · Cited by 19
Keshavjee, B., Lambelet, V., Coppola, H., Viertl, D., Prior, J. O., Kappeler, L., Armengaud, J.-B., Chouraqui, J.-P., Chehade, H., Vanderriele, P., et al. (2022) · Antioxidants · doi:10.3390/antiox11091695 · Cited by 17
Toffanin, S., Cornellà, H., Harrington, A., Llovet, J. M., Groszmann, R. J., Iwakiri, Y., & Taddei, T. H. (2012) · Hepatology · doi:10.1002/hep.26080 · Cited by 15
Effect of malaria components on blood mononuclear cells involved in immune response
Punsawad, C. (2013) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(13)60151-3 · Cited by 13
Chu, J., & Guo, C. (2015) · Archiv der Pharmazie · doi:10.1002/ardp.201500349 · Cited by 15
Liu, D., Li, R., Li, M., Liang, Y., Wang, Z., Sun, Y., & Ge, P. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03608-z · Cited by 14
Qiu, Y., Laguna, J. C., Alegret, M., & Vilà, L. (2026) · Nutrients · doi:10.3390/nu18040679 · Cited by 14
Immune implication of FAM83D gene in hepatocellular carcinoma
Meng, T., Tong, Z., Yang, M., Zhang, Y., Liu, Y., Wang, Z., Zhu, L., & Wu, J. (2021) · Bioengineered · doi:10.1080/21655979.2021.1950260 · Cited by 14
Khatab, L. A., Abdel-Raheem, I. T., & Ghoneim, A. I. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02176-1 · Cited by 14
Yin, Q., Song, X., Yang, P., Yang, W., Li, X., Wang, X., & Wang, S. (2022) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2022.102649 · Cited by 14
Alanazi, A. A. H., Nagi, M. N., Alhareth, D. Y., Al‐Hamamah, M. A., Mahmoud, M. A., Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., Harisa, G. I., et al. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.01.005 · Cited by 14
Li, S., Xie, J., Zhang, D., Zhao, G., Bai, Y., Li, K., Li, X., Li, Q., Tang, X., & Ge, X. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108897 · Cited by 14
Pesti‐Asbóth, G., Szilágyi, E., Molnár, P. B., Oláh, J., Babinszky, L., Czeglédi, L., Cziáky, Z., Paholcsek, M., Stündl, L., & Remenyik, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290310 · Cited by 14
Modelling porcine NAFLD by deletion of leptin and defining the role of AMPK in hepatic fibrosis
Tan, T., Song, Z., Li, W., Wang, R., Zhu, M., Liang, Z., Bai, Y., Wang, Q., Wu, H., Hu, X., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01124-1 · Cited by 14
Abo-Zaid, O. A., Abdel-Maksoud, M. A., Saleh, I. A. S., El‐Tayeb, M. A., El-Sonbaty, S. M., Shoker, F. E., Salem, M. A., Emad, A. M., Mani, S., Rao, A. K. D. M., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116274 · Cited by 14
Abo‐Raya, M. H., Shi, Y., Wang, Y., Sayed, S. M. H., & Shukry, M. (2024) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13984 · Cited by 15
Acuña-Pilarte, K., Reichert, E. C., Green, Y. S., Halberg, L. M.-T., Golkowski, M. G., Maguire, K. M., Mimche, P. N., Kamdem, S. D., Hu, P.-A., Wright, J., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000001070 · Cited by 15
Immune Checkpoints and the Immunology of Liver Fibrosis
Tsomidis, I., Voumvouraki, A., & Kouroumalis, E. (2025) · Livers · doi:10.3390/livers5010005 · Cited by 14
Schneider, A. T., Koppe, C., Crouchet, É., Papargyriou, A., Singer, M. T., Büttner, V., Keysberg, L. S., Szydlowska, M., Jühling, F., Moehlin, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56493-7 · Cited by 14
Self-citationMoon, M., Kim, H., Kim, M., Uhm, S., Park, J. W., Suk, K. T., Park, J., Kim, D., & Kim, S. E. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4215 · Cited by 14
Koppe, C., Reisinger, F., Wehr, K., Vucur, M., Trautwein, C., Tacke, F., Heikenwälder, M. F., & Luedde, T. (2019) · Cancers · doi:10.3390/cancers11070999 · Cited by 14
Self-citationZhou, T.-H., Su, J., Qin, R., Chen, X., Ju, G., & Miao, S. (2020) · Cancer Management and Research · doi:10.2147/cmar.s279194 · Cited by 14
Ciceu, A., Baltă, C., Herman, H., Gharbia, S., Ignat, S.-R., Dinescu, S., Váradi, J., Fenyvesi, F., Gyöngyösi, S., Hermenean, A. O., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041869 · Cited by 14
Citrus peel derived poly-methoxylated flavones (PMF)
Vajdi, M., & Farhangi, M. A. (2021) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000710 · Cited by 14
Qin, T., Wang, M., Zhang, T., Wang, Y., Zhang, Y., Hasnat, M., Zhuang, Z., Ding, Y., & Peng, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.775730 · Cited by 14
Vats, R., Li, Z., Ju, E.-M., Dubey, R. K., Kaminski, T. W., Watkins, S. C., & Pradhan‐Sundd, T. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00408.2021 · Cited by 14
The anti-inflammatory effect of Pien Tze Huang in non-alcoholic fatty liver disease
Lian, B., Cai, L., Zhang, Z., Fen, L., Li, Z., Zhang, X.-K., & Jiang, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113076 · Cited by 14
Bai, L., Wang, Y., Chen, Y., Li, H., Zhu, S., Liu, Y., Song, Z., & Duan, S. (2022) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13682 · Cited by 14
Molecular mechanisms of hepatic dysfunction in sickle cell disease: lessons from Townes mouse model
Pradhan‐Sundd, T., Kato, G. J., & Novelli, E. M. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00175.2022 · Cited by 16
Gehrke, N., Wörns, M., Mann, A., Huber, Y., Hövelmeyer, N., Longerich, T., Waisman, A., Galle, P. R., & Schattenberg, J. M. (2016) · Oncotarget · doi:10.18632/oncotarget.10893 · Cited by 14
Lange, N., Tsamo, A. T., Wegscheid, C., Mkounga, P., Nkengfack, A. E., Loscher, C., Sass, G., & Tiegs, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160843 · Cited by 14
Mohamed, D. I., Khairy, E., Khedr, S. A., Habib, E. K., Elayat, W. M., & El-Kharashi, O. A. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104602 · Cited by 14
Zhang, M., Dong, X., Zhang, D., Chen, X., & Zhu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.13891 · Cited by 14
Natural Products in Liver Fibrosis Management: A Five-year Review
Wang, T., Lü, Z., Sun, G., He, K.-Y., Chen, Z., Qu, X.-H., & Han, X. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673288458240203064112 · Cited by 14
Bertran, L., Eigbefoh-Addeh, A., Portillo-Carrasquer, M., Barrientos‐Riosalido, A., Binetti, J., Aguilar, C., Chicote, J. U., Bartra, H., Artigas, L., Coma, M., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10061315 · Cited by 13
Yu, Y., Fan, Y., Mei, W.-L., Xu, X., Chen, Y., Zhao, Y., Ruan, B., Shen, Z., Lu, Y., Zheng, S., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117013 · Cited by 13
Rahman, M. A., Rakib-Uz-Zaman, S. M., Chakraborti, S., Bhajan, S. K., Gupta, R. D., Jalouli, M., Parvez, M. A. K., Shaikh, M. H., Apu, E. H., Harrath, A. H., et al. (2024) · Cells · doi:10.3390/cells13141186 · Cited by 13
Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death
Mooli, R. G. R., Mukhi, D., Watt, M., Nagati, V., Reed, S. M., Gandhi, N. K., Oertel, M., & Ramakrishnan, S. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313114 · Cited by 14
Zhou, Y., Wen, T., Yang, S. L., Meng, B., Wei, J., Zhang, J., Wang, L., & Shen, X. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119439 · Cited by 14
Multifaceted Tumor Stromal Fibroblasts
Li, J., Chen, L., & Qin, Z. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0109-8 · Cited by 13
Zhou, W., Liu, Q., Zang, X., Hu, M., Yue, Y., Wang, Y., Lv, C., & Du, Z. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13240 · Cited by 13
Repurposing mesalazine against cardiac fibrosis in vitro
Hoffmann, M., Kant, T. A., Emig, R., Rausch, J. S. E., Newe, M., Schubert, M., Künzel, K., Winter, L., Klapproth, E., Peyronnet, R., et al. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01998-9 · Cited by 14
Ziyuglycoside II inhibits the growth of digestive system cancer cells through multiple mechanisms
Zhong, Y., Li, X., Zhou, F., Cai, Y., Sun, R., & Liu, R. (2021) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(21)60033-x · Cited by 13
Hemistepsin a Induces Apoptosis of Hepatocellular Carcinoma Cells by Downregulating STAT3
Cho, I. J., Kim, J. K., Kim, E. O., Park, S. M., Kim, S. C., Ki, S. H., & Ku, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094743 · Cited by 13
MicroRNAs in organ fibrosis: From molecular mechanisms to potential therapeutic targets
Zhao, H., Feng, Y., Liu, T., Wang, J., & Yu, J. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153588 · Cited by 13
Sun, R., Xiao, R., Lv, P., Guo, F., Gong, Y., & Yan, M. (2022) · Journal of Oleo Science · doi:10.5650/jos.ess21228 · Cited by 13
Baicalin prevents fibrosis of human trabecular meshwork cells via inhibiting the MyD88/NF-κB pathway
Li, L., Liu, Q., Shi, L., Zhou, X., Wu, W., Wang, X., Wang, L., & Wu, Z. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175425 · Cited by 13
Inflammation and Hepatic Fibrosis, Then Hepatocellular Carcinoma
Kwon, O. S., Choi, S. H., & Kim, J. H. (2015) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2015.66.6.320 · Cited by 13
Pentoxifylline inhibits liver fibrosis via hedgehog signaling pathway
Li, H., Hua, J., Guo, C., Wang, W., Wang, B., Yang, D., Wei, P., & Lu, Y. (2016) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-016-1594-7 · Cited by 13
Cheng, K. L. O. H. Y. (2015) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000291 · Cited by 13
Evaluation of the Liver Toxicity of Pterocephalus hookeri Extract via Triggering Necrosis
Wang, R., Dong, Z., Zhang, X., Mao, J., Meng, F., Lan, X., Liao, Z., & Chen, M. (2019) · Toxins · doi:10.3390/toxins11030142 · Cited by 13
Wu, D., Liao, Z.-D., Chen, F., Zhang, W., Ren, Y.-S., Wang, C.-C., Chen, X., Peng, D., & Kong, L. (2019) · Molecules · doi:10.3390/molecules24122246 · Cited by 13
Exercise reduces hyperlipidemia‑induced kidney damage in apolipoprotein E‑deficient mice
Qian, C., Yang, Q., Guo, L., Zhu, H., You, X., Liu, H., & Sun, Y. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9585 · Cited by 13
The Dark Side of the Force: When the Immune System Is the Fuel of Tumor Onset
Digifico, E., Balinzo, S., & Belgiovine, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031224 · Cited by 15
Nowatzky, J., Knorr, A., Hirth‐Dietrich, C., Siegling, A., Volk, H., Limmer, A., Knolle, P. A., & Weber, O. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01086.x · Cited by 13
Hsu, D.-Z., Chu, P., Li, Y.-H., Chandrasekaran, V. R. M., & Liu, M. (2012) · Toxicology · doi:10.1016/j.tox.2012.05.001 · Cited by 13
Fu, R., Zu, S.-J., Liu, Y.-J., Li, J.-C., Dang, W.-Z., Liao, L.-P., Liu, L.-P., Chen, P.-Y., Huang, H.-M., Wu, K.-H., et al. (2022) · Bioengineered · doi:10.1080/21655979.2022.2066756 · Cited by 12
Yang, H., Atak, D., Yuan, M., Li, M., Altay, Ö., Demirtas, E., Peltek, İ. B., Ulukan, B., Yiğit, B., Sipahioglu, T., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101935 · Cited by 13
Interactions between hepatic stellate cells and immune cells: Implications for liver fibrosis
Xie, D., Huang, Y., Yu, Y., Jin, W., Zhang, X., & Yu, F. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168062 · Cited by 12
Léger, T., Balaguer, P., Hégarat, L. L., & Fessard, V. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.130083 · Cited by 12
Al-Harbi, N. O., Imam, F., Al-Harbi, M. M., Qamar, W., Aljerian, K., Anwer, M. K., Alharbi, M., Almudimeegh, S., Alhamed, A. S., & Alshamrani, A. A. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.05.022 · Cited by 12
Protective Effects of Phytic Acid on CCl4-Induced Liver Fibrosis in Mice
Xu, Z., Zhao, C., Lan, T., Han, Y., Yang, N., Wang, C., Tao, M., Li, H., Song, Y., & Ma, X. (2023) · Journal of Food Biochemistry · doi:10.1155/2023/6634450 · Cited by 13
Xu, P., Liu, J., Li, Z., Kan, X., Hu, G., Cao, Y., Guo, W., & Fu, S. (2023) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-023-00406-6 · Cited by 12
Lee, D.-Y., Shin, J., Shin, Y.-J., Han, S.-W., & Kim, D.-H. (2023) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2310.10006 · Cited by 12
Metadata
- Authors
- Luedde, T., & Schwabe, R. F.
- Affiliations
- Universitätsklinikum Aachen (DE)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Luedde, Tom
- Schwabe, Robert F.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2011-02
- Volume
- 8
- Issue
- 2
- Pages
- 108-118
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- PMC
- PMC3295539
- OpenAlex
- W1976777085
- Cited by
- 1,345
- References
- 137
- Citations by year
- 2026: 97 · 2025: 99 · 2024: 119 · 2023: 109 · 2022: 122 · 2021: 156 · 2020: 120 · 2019: 95 · 2018: 79 · 2017: 76 · 2016: 66 · 2015: 68 · 2014: 51 · 2013: 38 · 2012: 42
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u54ca126513-03)
- National Institute on Alcohol Abuse and Alcoholism (R01AA020211)
- National Cancer Institute (U54 CA126513.)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK076920)
- National Center for Complementary and Integrative Health (R21AT003878)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- NF-κB, liver fibrosis, hepatocellular carcinoma, chronic liver disease, liver cirrhosis, chronic liver injury, liver inflammation, hepatocytes, non-parenchymal liver cells, NF-κB inhibition, hepatocyte viability
- MeSH terms
- Cell Survival, Fibrosis, Carcinoma, Hepatocellular, Homeostasis, Humans, Liver, Liver Neoplasms, NF-kappa B, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review